×
2761 Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours
Nicum S., Boyle L., Strauss V., Gourley C., Hall M., Montes A., Abraham J., Clamp A., Kennedy R., Banerjee S., Roberts C.
DOI
10.1016/s0959-8049(16)31527-1
Type
Conference paper
Publisher
Elsevier BV
Publication Date
2015-09-01T00:00:00+00:00
Volume
51
Pages
S551 - S551